Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

3D-QSAR, molecular docking, and molecular dynamics simulation study of thieno[3,2-b]pyrrole-5-carboxamide derivatives as LSD1 inhibitors
Yongtao Xu, Zihao He, Hongyi Liu, et al.
RSC Advances (2020) Vol. 10, Iss. 12, pp. 6927-6943
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Pyrrole-containing hybrids as potential anticancer agents: An insight into current developments and structure-activity relationships
Long Li, Han Zhang, Zhihui Zhou, et al.
European Journal of Medicinal Chemistry (2024) Vol. 273, pp. 116470-116470
Closed Access | Times Cited: 9
3D‐QSAR, molecular docking, molecular dynamics, and ADME/T analysis of marketed and newly designed flavonoids as inhibitors of Bcl‐2 family proteins for targeting U‐87 glioblastoma
Alireza Poustforoosh, Sanaz Faramarz, Mohammad Hadi Nematollahi, et al.
Journal of Cellular Biochemistry (2021) Vol. 123, Iss. 2, pp. 390-405
Closed Access | Times Cited: 46
Lysine-Specific Demethylase 1 Inhibitors: A Comprehensive Review Utilizing Computer-Aided Drug Design Technologies
Di Han, Jiarui Lu, Baoyi Fan, et al.
Molecules (2024) Vol. 29, Iss. 2, pp. 550-550
Open Access | Times Cited: 6
Annual review of LSD1/KDM1A inhibitors in 2020
Dong‐Jun Fu, Jun Li, Bin Yu
European Journal of Medicinal Chemistry (2021) Vol. 214, pp. 113254-113254
Closed Access | Times Cited: 31
In Silico Drug Design and Analysis of Dual Amyloid-Beta and Tau Protein-Aggregation Inhibitors for Alzheimer’s Disease Treatment
Nisha Job, Venkatesan S. Thimmakondu, Krishnan Thirumoorthy
Molecules (2023) Vol. 28, Iss. 3, pp. 1388-1388
Open Access | Times Cited: 11
Synthesis and biological activities of novel thieno[2,3-b]pyrrol-5-one derivatives: antioxidant and anticancer potential
M. Maya Pai, Basappa C. Yallur, D.H. Manjunatha, et al.
Journal of Sulfur Chemistry (2025), pp. 1-17
Closed Access
Interaction behavior between five flavonoids and pepsin: Spectroscopic analysis and molecular docking
Jie Yu, Xiangrong Li, Hongyi Liu, et al.
Journal of Molecular Structure (2020) Vol. 1223, pp. 128978-128978
Closed Access | Times Cited: 28
Computational Prediction of 3,5-Diaryl-1H-Pyrazole and spiropyrazolines derivatives as potential acetylcholinesterase inhibitors for alzheimer disease treatment by 3D-QSAR, molecular docking, molecular dynamics simulation, and ADME-Tox
Moulay Ahfid El Alaouy, Marwa Alaqarbeh, Mohamed Ouabane, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 18, pp. 9547-9560
Closed Access | Times Cited: 10
3‐arylcoumarins as the potential neuroprotective agents for the treatment of Alzheimer's disease by targeting monoamine oxidase: Molecular docking, 3D QSAR, and molecular dynamics simulations
Ammara Fayyaz, Syeda Abida Ejaz, Mubashir Aziz, et al.
Vietnam Journal of Chemistry (2025)
Closed Access
Discovery of new potent lysine specific histone demythelase-1 inhibitors (LSD-1) using structure based and ligand based molecular modelling and machine learning
Shada J. Alabed, Malek Zihlif, Mutasem O. Taha
RSC Advances (2022) Vol. 12, Iss. 55, pp. 35873-35895
Open Access | Times Cited: 9
Structural modification of 4, 5-dihydro-[1, 2, 4] triazolo [4, 3-f] pteridine derivatives as BRD4 inhibitors using 2D/3D-QSAR and molecular docking analysis
Jianbo Tong, Ding Luo, Yi Feng, et al.
Molecular Diversity (2021) Vol. 25, Iss. 3, pp. 1855-1872
Closed Access | Times Cited: 12
Synthesis of novel purine derivatives: Antiplatelet aggregation activity evaluation and 3D‐QSAR analysis
Shunlai Li, Yajing Ren, Qiwen He, et al.
Journal of Heterocyclic Chemistry (2022) Vol. 59, Iss. 11, pp. 2016-2024
Closed Access | Times Cited: 8
Unraveling the Binding Mode of Cyclic Adenosine–Inosine Monophosphate (cAIMP) to STING through Molecular Dynamics Simulations
Meiting Wang, Baoyi Fan, Wenfeng Lu, et al.
Molecules (2024) Vol. 29, Iss. 11, pp. 2650-2650
Open Access | Times Cited: 1
3D-QSAR Studies of 1,2,4-Oxadiazole Derivatives as Sortase A Inhibitors
Neda Shakour, Farzin Hadizadeh, Prashant Kesharwani, et al.
BioMed Research International (2021) Vol. 2021, pp. 1-10
Open Access | Times Cited: 10
Investigation of [3H]diazepam derivatives as allosteric modulators of GABAA receptor α1β2γ2 subtypes: combination of molecular docking/dynamic simulations, pharmacokinetics/drug-likeness prediction, and QSAR analysis
R. Djebaïli, Samir Kenouche, Ismail Daoud, et al.
Structural Chemistry (2022) Vol. 34, Iss. 3, pp. 791-823
Open Access | Times Cited: 7
Thieno[3,2-b]pyrrole as a privileged scaffold in medicinal chemistry: An exploration of synthetic strategies and anticancer attributes
Kapil Kumar Goel, Sorabh Lakhanpal, Roshan Kumar, et al.
Journal of Molecular Structure (2024) Vol. 1321, pp. 139654-139654
Closed Access | Times Cited: 1
Docking-based 3D-QSAR, molecular dynamics simulation studies and virtual screening of novel ONC201 analogues targeting Mitochondrial ClpP
Tang Li, Wan Pang, Jie Wang, et al.
Journal of Molecular Structure (2021) Vol. 1245, pp. 131025-131025
Closed Access | Times Cited: 9
Machine-Learning-Enabled Virtual Screening for Inhibitors of Lysine-Specific Histone Demethylase 1
Jiajun Zhou, Shiying Wu, Boon Giin Lee, et al.
Molecules (2021) Vol. 26, Iss. 24, pp. 7492-7492
Open Access | Times Cited: 8
A Quinquennial Review of Potent LSD1 Inhibitors Explored for the Treatment of Different Cancers, with Special Focus on SAR Studies
Khursheed Ahmad Sheikh, Ashif Iqubal, Mohammad Mumtaz Alam, et al.
Current Medicinal Chemistry (2023) Vol. 31, Iss. 2, pp. 152-207
Closed Access | Times Cited: 2
Unveiling Arformoterol as a potent LSD1 inhibitor for breast cancer treatment: A comprehensive study integrating 3D-QSAR pharmacophore modeling, molecular docking, molecular dynamics simulations and in vitro assays
Hamzeh Rezaei, Vahid Zarezade, Iraj Khodadadi, et al.
International Journal of Biological Macromolecules (2023) Vol. 258, pp. 129048-129048
Closed Access | Times Cited: 2
QSAR Modeling, Molecular Docking and Molecular Dynamics Simulations Studies of Lysine-Specific Demethylase 1 (LSD1) Inhibitors as Anticancer Agents
Rahman Abdizadeh, Esfandiar Heidarian, Farzin Hadizadeh, et al.
Anti-Cancer Agents in Medicinal Chemistry (2020) Vol. 21, Iss. 8, pp. 987-1018
Closed Access | Times Cited: 4
4-Phthalimidobenzenesulfonamide Derivatives as Acetylcholinesterase and Butyrylcholinesterase Inhibitors: DFTs, 3D-QSAR, ADMET, and Molecular Dynamics Simulation
Syeda Abida Ejaz, Ammara Fayyaz, Hafiz Mohammad Kashif Mahmood, et al.
Neurodegenerative Diseases (2022) Vol. 22, Iss. 3-4, pp. 122-138
Closed Access | Times Cited: 3
Essential Structural Profile of Novel Adenosine Derivatives as Antiplatelet Aggregation Inhibitors based on 3D-QSAR Analysis
Shunlai Li, Pengyu Zheng, Yajing Ren, et al.
Letters in Drug Design & Discovery (2024) Vol. 21, Iss. 15, pp. 3115-3124
Closed Access
Virtual Tools and Screening Designs for Drug Discovery and New Drug Development
Sonal Dubey
BENTHAM SCIENCE PUBLISHERS eBooks (2024), pp. 108-134
Closed Access
Thienopyrroles-Emerging Therapeutic Agents in Modern Medicine
G. K. Prashanth, H. S. Lalithamba, Srilatha Rao, et al.
Advances in bioinformatics and biomedical engineering book series (2024), pp. 111-134
Closed Access
Page 1 - Next Page

Scroll to top